In-Depth Examination of Segments, Industry Trends, and Key Competitors in the Blood Platelets Market

The blood platelets market is poised for substantial growth in the coming years, driven by several critical healare trends and technological advances. With a rising number of patients requiring platelet transfusions and continuous improvements in platelet collection and storage, this sector is attracting significant attention. Let's explore the market's projected size, key players, emerging trends, and important segments shaping its future.

Blood Platelets Market Size Outlook and Growth Forecast Through 2030
The blood platelets market is anticipated to expand significantly, reaching a market value of $9.28 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 6.7% during the forecast period. Several factors contribute to this upward trend, including a higher incidence of thrombocytopenia cases, increasing demand from oncology centers, the broadening availability of advanced transfusion services, and heightened focus on transfusion safety. Additionally, investments aimed at developing next-generation platelet storage technologies are supporting market expansion. Key trends expected to dominate the market include greater utilization of apheresis-derived platelets, wider adoption of pathogen-reduced platelet products, the rollout of automated platelet collection systems, ongoing efforts to extend platelet shelf life, and improved monitoring techniques for platelet quality.

Download a free sample of the blood platelets market report:
https://www.thebusinessresearchcompany.com/report/blood-platelets-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Top Companies Leading the Blood Platelets Market Landscape
The blood platelets sector features numerous influential companies driving innovation and market growth. Notable market leaders include Fresenius Kabi, Grifols S.A., CSL Behring, Octapharma AG, Terumo Corporation, Cerus Corporation, Macopharma, Biotest AG, Kedrion Biopharma, Bio Products Laboratory Ltd, LFB Group, Hemanext Inc, Cellphire Inc, American Red Cross, Sanquin, Canadian Blood Services, Australian Red Cross Lifeblood, New York Blood Center, and Vitalant, among others.
In a strategic move in December 2023, Sysmex Corporation, a Japanese healare and diagnostics firm, acquired additional shares in Megakaryon Corporation. This acquisition aims to accelerate the commercialization of high-quality induced pluripotent stem (iPS) cell-derived platelets by leveraging Megakaryon's specialized technology. The collaboration is expected to enhance group synergies and promote advancements in regenerative medicine through improved automation and quality control. Megakaryon is recognized for developing iPS cell-derived platelets designed to offer safer and more sustainable blood transfusions.

Emerging Innovations and Safety Enhancements Influencing the Blood Platelets Market
Leading companies within the blood platelets domain are focusing on the development of next-generation closed system transfer devices (CSTD) to improve safety and usability. These devices aim to reduce contamination risks while ensuring compliance with strict healare regulations.
Full-volume syringe units, designed to deliver the entire liquid content without requiring dilution or mixing, represent a key innovation in this area. For example, in October 2023, Equashield, a US-based medical device company, introduced the EQUASHIELD Syringe Unit. This product gained FDA approval for full-volume use and enhances the safe handling of hazardous drugs by preventing vapor escape and plunger contamination. Its cost-effectiveness makes it a valuable solution for both drug compounding and administration.

The blood platelets market is poised for substantial growth in the coming years, driven by several critical healare trends and technological advances. With a rising number of patients requiring platelet transfusions and continuous improvements in platelet collection and storage, this sector is attracting significant attention. Let's explore the market's projected size, key players, emerging trends, and important segments shaping its future.

Blood Platelets Market Size Outlook and Growth Forecast Through 2030
The blood platelets market is anticipated to expand significantly, reaching a market value of $9.28 billion by 2030. This growth corresponds to a compound annual growth rate (CAGR) of 6.7% during the forecast period. Several factors contribute to this upward trend, including a higher incidence of thrombocytopenia cases, increasing demand from oncology centers, the broadening availability of advanced transfusion services, and heightened focus on transfusion safety. Additionally, investments aimed at developing next-generation platelet storage technologies are supporting market expansion. Key trends expected to dominate the market include greater utilization of apheresis-derived platelets, wider adoption of pathogen-reduced platelet products, the rollout of automated platelet collection systems, ongoing efforts to extend platelet shelf life, and improved monitoring techniques for platelet quality.

Download a free sample of the blood platelets market report:
https://www.thebusinessresearchcompany.com/report/blood-platelets-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR
Top Companies Leading the Blood Platelets Market Landscape
The blood platelets sector features numerous influential companies driving innovation and market growth. Notable market leaders include Fresenius Kabi, Grifols S.A., CSL Behring, Octapharma AG, Terumo Corporation, Cerus Corporation, Macopharma, Biotest AG, Kedrion Biopharma, Bio Products Laboratory Ltd, LFB Group, Hemanext Inc, Cellphire Inc, American Red Cross, Sanquin, Canadian Blood Services, Australian Red Cross Lifeblood, New York Blood Center, and Vitalant, among others.
In a strategic move in December 2023, Sysmex Corporation, a Japanese healare and diagnostics firm, acquired additional shares in Megakaryon Corporation. This acquisition aims to accelerate the commercialization of high-quality induced pluripotent stem (iPS) cell-derived platelets by leveraging Megakaryon's specialized technology. The collaboration is expected to enhance group synergies and promote advancements in regenerative medicine through improved automation and quality control. Megakaryon is recognized for developing iPS cell-derived platelets designed to offer safer and more sustainable blood transfusions.

Emerging Innovations and Safety Enhancements Influencing the Blood Platelets Market
Leading companies within the blood platelets domain are focusing on the development of next-generation closed system transfer devices (CSTD) to improve safety and usability. These devices aim to reduce contamination risks while ensuring compliance with strict healare regulations.
Full-volume syringe units, designed to deliver the entire liquid content without requiring dilution or mixing, represent a key innovation in this area. For example, in October 2023, Equashield, a US-based medical device company, introduced the EQUASHIELD Syringe Unit. This product gained FDA approval for full-volume use and enhances the safe handling of hazardous drugs by preventing vapor escape and plunger contamination. Its cost-effectiveness makes it a valuable solution for both drug compounding and administration.

Detailed Segmentation of the Global Blood Platelets Market
The report segments the blood platelets market by several important categories:
1) Platelet Type: Whole Blood Derived Platelets and Apheresis Derived Platelets
2) Application Areas: Platelet Function Disorder, Hemophilia, Thrombocytopenia, and Perioperative Indications
3) End-Users: Hospitals, Ambulatory Surgical Centers, Blood Banks, Research Laboratories, Specialty Clinics, Cancer Treatment Centers, Trauma Centers, and other users

Additional subcategories break down platelet types further:
- Whole Blood Derived Platelets include Leukocyte-Reduced, Non-Leukocyte-Reduced, and Pathogen-Reduced variants
- Apheresis Derived Platelets encompass Single-Donor, Leukocyte-Reduced, and Pathogen-Reduced options

This segmentation provides a comprehensive understanding of the market's diverse product offerings and their respective applications across healare settings.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.